$35.65
1.67% yesterday
Nasdaq, Oct 03, 10:00 pm CET
ISIN
US45720L1070
Symbol
INBX

Inhibrx Inc Target price 2025 - Analyst rating & recommendation

Inhibrx Inc Classifications & Recommendation:

Hold
50%
Sell
50%

Inhibrx Inc Price Target

Target Price $12.24
Price $35.65
Deviation
Number of Estimates 3
3 Analysts have issued a price target Inhibrx Inc 2026 . The average Inhibrx Inc target price is $12.24. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 0 Analysts recommend Inhibrx Inc to buy, 3 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Inhibrx Inc stock has an average upside potential 2026 of . Most analysts recommend the Inhibrx Inc stock at Sell or hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 0.20 1.33
88.89% 563.00%
Net Margin 843,785.00% -9,045.54%
6,392.73% 101.07%

3 Analysts have issued a sales forecast Inhibrx Inc 2025 . The average Inhibrx Inc sales estimate is

$1.3m
Unlock
. This is
5.29% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.4m 2.50%
Unlock
, the lowest is
$1.3m 9.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $200k 88.89%
2025
$1.3m 563.00%
Unlock
2026
$4.4m 230.77%
Unlock

3 Inhibrx Inc Analysts have issued a net profit forecast 2025. The average Inhibrx Inc net profit estimate is

$-120m
Unlock
. This is
0.37% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-115m 4.27%
Unlock
, the lowest is
$-123m 2.57%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $1.7b 799.19%
2025
$-120m 107.11%
Unlock
2026
$-138m 14.77%
Unlock
2027
$-96.6m 29.84%
Unlock

Net Margin

2024 843,785.00% 6,392.73%
2025
-9,045.54% 101.07%
Unlock
2026
-3,138.46% 65.30%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 112.62 -8.28
2,299.61% 107.35%
P/E negative
EV/Sales 323.62

3 Analysts have issued a Inhibrx Inc forecast for earnings per share. The average Inhibrx Inc EPS is

$-8.28
Unlock
. This is
6.43% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-8.53 9.64%
Unlock
, the lowest is
$-7.96 2.31%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $112.62 2,299.61%
2025
$-8.28 107.35%
Unlock
2026
$-9.51 14.86%
Unlock
2027
$-6.67 29.86%
Unlock

P/E ratio

Current -4.58 3,356.79%
2025
-4.30 6.16%
Unlock
2026
-3.75 12.79%
Unlock
2027
-5.35 42.67%
Unlock

Based on analysts' sales estimates for 2025, the Inhibrx Inc stock is valued at an EV/Sales of

323.62
Unlock
and an P/S ratio of
389.45
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 306.51 25,857.14%
2025
323.62 5.58%
Unlock
2026
97.84 69.77%
Unlock

P/S ratio

Current 368.86 203.74%
2025
389.45 5.58%
Unlock
2026
117.74 69.77%
Unlock

Current Inhibrx Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JMP Securities
Locked
Locked
Locked Aug 22 2025
JMP Securities
Locked
Locked
Locked May 15 2025
Citizens Capital Markets
Locked
Locked
Locked Mar 18 2025
JMP Securities
Locked
Locked
Locked Jan 22 2025
Analyst Rating Date
Locked
JMP Securities:
Locked
Locked
Aug 22 2025
Locked
JMP Securities:
Locked
Locked
May 15 2025
Locked
Citizens Capital Markets:
Locked
Locked
Mar 18 2025
Locked
JMP Securities:
Locked
Locked
Jan 22 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today